Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..

BACKGROUND: Epithelial to mesenchymal transition (EMT) endows cancer cells with pro-metastatic properties, which appear most effective when cells enter an intermediate hybrid (H) state, characterized by integrated mesenchymal (M) and epithelial (E) traits. The reasons for this advantage are poorly known and, especially, it is totally unexplored whether the interplay between H-cells and NK cells could have a role. Here we characterize the pro-metastatic mechanics of non-small cell lung cancer (NSCLC) H-cells and their subset of cancer-initiating cells (CICs), dissecting crucial interactions with NK cells.

METHODS: Human lung cancer cell lines and sublines representative of E, M, or H states, assessed by proteomics, were analyzed in vivo for their tumor-forming and disseminating capabilities. Interactions with NK cells were investigated in vitro using migration assays, cytotoxic degranulation assays, and evaluation of CD133+ CICs modulation after coculture, and validated in vivo through NK cell neutralization assays. Correlation between EMT status, NK cell infiltration, and survival data, was evaluated in a cohort of surgically resected NSCLC cases (n=79).

RESULTS: We demonstrated that H-cells, have limited dissemination capability but show the highest potential to initiate metastases in vivo. This property was related to their ability to escape NK cell surveillance. Mechanistically, H-cells expressed low levels of NK-attracting chemokines (CXCL1 and CXCL8), generating poorly infiltrated metastases. Accordingly, proteomics and GO enrichment analysis of E, H, M cell lines showed that the related secretory processes could change during EMT.Furthermore, H-CICs uniquely expressed high levels of the inhibitory ligand B7-H3, which protected H-CIC from NK cell-mediated clearance. In vivo neutralization assays confirmed that, indeed, the pro-metastatic properties of H-cells are poorly controlled by NK cells.Finally, the analysis of patients revealed that detection of hybrid phenotypes associated with low NK infiltration in NSCLC clinical specimens could identify a subset of patients with poor prognosis.

CONCLUSIONS: Our study demonstrates that H-cells play a central role in the metastatic spread in NSCLC. Such pro-metastatic advantage of H-cells is supported by their altered interaction with NK cells and by the critical role of B7-H3 in preserving their H-CIC component, indicating B7-H3 as a potential target in combined NK-based therapies.

Medienart:	E-Artikel

Erscheinungsjahr:	2024
Erschienen:	2024

Enthalten in:	Zur Gesamtaufnahme - volume:12
Enthalten in:	Journal for immunotherapy of cancer - 12(2024), 3 vom: 07. März

Sprache:	Englisch

Beteiligte Personen:

Parodi, Monica [VerfasserIn] Centonze, Giovanni [VerfasserIn] Murianni, Fabio [VerfasserIn] Orecchia, Paola [VerfasserIn] Andriani, Francesca [VerfasserIn] Roato, Ilaria [VerfasserIn] Gardelli, Cecilia [VerfasserIn] Balsamo, Melissa [VerfasserIn] Moro, Massimo [VerfasserIn] Taiè, Giulia [VerfasserIn] Pastorino, Ugo [VerfasserIn] Petretto, Andrea [VerfasserIn] Lavarello, Chiara [VerfasserIn] Milione, Massimo [VerfasserIn] Sozzi, Gabriella [VerfasserIn] Roz, Luca [VerfasserIn] Vitale, Massimo [VerfasserIn] Bertolini, Giulia [VerfasserIn]

Links:	Volltext

Themen:	Immunity, Innate Journal Article Killer Cells, Natural Non-Small Cell Lung Cancer Receptors, Antigen Transcription Factors Tumor Escape

Anmerkungen:	Date Completed 11.03.2024 Date Revised 12.03.2024 published: Electronic Citation Status MEDLINE

doi:	10.1136/jitc-2023-007895

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	NLM369483677